US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 24.560
  • -1.600-6.12%
Close Dec 18 16:00 ET
  • 25.290
  • +0.730+2.97%
Pre 05:14 ET
2.50BMarket Cap-6.86P/E (TTM)

About Dyne Therapeutics Company

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases.  The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Company Profile

SymbolDYN
Company NameDyne Therapeutics
Listing DateSep 17, 2020
Issue Price19.00
Founded2017
CEOMr. John G. Cox
MarketNASDAQ
Employees141
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-786-8230
Websitehttp://www.dyne-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • John G. Cox
  • Director, President and Chief Executive Officer
  • --
  • Wildon Farwell, M.D.,M.P.H.
  • Chief Medical Officer
  • --
  • Dr. Oxana Beskrovnaya, PhD
  • Chief Scientific Officer
  • --
  • Richard William Scalzo
  • Senior Vice President, Head of Finance and Administration, Principal Financial and Accounting Officer
  • --
  • Jason P. Rhodes
  • Chairman of the Board
  • 283.17K
  • Dirk Kersten
  • Independent Director
  • 262.67K
  • Dr. Catherine Stehman-Breen, M.D.
  • Independent Director
  • 253.92K
  • Edward M. Hurwitz, J.D.
  • Independent Director
  • 250.17K
  • David Charles Lubner, C.P.A.,M.S.
  • Independent Director
  • 264.17K
  • Dr. Carlo Incerti
  • Independent Director
  • 250.17K
Heat List
US
Overall
Symbol
Price
% Chg

No Data